Details for Patent: 9,808,465
✉ Email this page to a colleague
Which drugs does patent 9,808,465 protect, and when does it expire?
Patent 9,808,465 protects APONVIE and CINVANTI and is included in two NDAs.
This patent has nine patent family members in five countries.
Summary for Patent: 9,808,465
Title: | Emulsion formulations of aprepitant |
Abstract: | Disclosed herein are novel pharmaceutical formulations of aprepitant suitable for parenteral administration including intravenous administration. Also included are formulations including both aprepitant and dexamethasone sodium phosphate. The pharmaceutical formulations are stable oil-in-water emulsions for non-oral treatment of emesis and are particularly useful for treatment of subjects undergoing highly emetogenic cancer chemotherapy. |
Inventor(s): | Ottoboni; Thomas B. (Belmont, CA), Han; Han (Mountain View, CA) |
Assignee: | Heron Therapeutics, Inc. (Redwood City, CA) |
Application Number: | 14/859,013 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,808,465 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,808,465
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Heron Theraps Inc | APONVIE | aprepitant | EMULSION;INTRAVENOUS | 216457-001 | Sep 16, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | A METHOD OF ADMINISTERING APREPITANT FOR PREVENTION OF POST-OPERATIVE NAUSEA AND VOMITING | ⤷ Try a Trial | ||||
Heron Theraps Inc | CINVANTI | aprepitant | EMULSION;INTRAVENOUS | 209296-001 | Nov 9, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF NAUSEA AND VOMITING, INCLUDING THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING ASSOCIATED WITH INITIAL AND REPEAT COURSES OF HIGHLY OR MODERATELY EMETOGENIC CANCER CHEMOTHERAPY | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,808,465
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
China | 106852118 | ⤷ Try a Trial | |||
European Patent Office | 3193830 | ⤷ Try a Trial | |||
Japan | 2017533183 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |